Reading size

PACK IN HAND · ONE-PAGE CHECK

Medicine pack check sheet

Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.

Published record starting point

Record display name
CEFTIN
Generic name / active ingredient
cefuroxime axetil
Dosage-form class
Cefuroxime axetil oral tablets and reconstituted oral suspension; mg per tablet and mg/5 mL use different measurement bases and cannot be directly exchanged from the numbers alone
Route
Oral
Record reviewed
2026-08-29

Copy from the pack in hand

Source-linked reading points

  • Tablet 125, 250 and 500 mg values are per tablet; suspension 125 or 250 mg/5 mL values are concentrations per 5 mL after reconstitution. Matching numbers do not permit self-substitution between tablets and suspension, and FDA label material states that the forms are not bioequivalent and are not directly substitutable milligram for milligram.
  • Use the pharmacy label and an oral dosing device for the reconstituted Canadian suspension; an ordinary kitchen spoon is not an accurate dosing device. The monograph requires refrigeration at 2–8°C and disposal of the remaining reconstituted suspension after 10 days. The site does not convert the concentration into individual millilitres.
  • The Canadian monograph recommends use with food for optimal absorption, but this page does not decide personal timing or extend that statement to historical U.S. tablets, another brand or another market. Check the exact pack and current local label first.
  • Before use, disclose cephalosporin, penicillin or other drug allergies, kidney problems and the complete medicine list. Breathing difficulty, swelling of the face/lips/tongue/throat, fainting, a severe skin reaction or chest discomfort with allergic features requires immediate local emergency care. Severe, persistent or bloody diarrhoea needs prompt medical assessment.

Reviewed presentation examples — compare every field

  • Equivalent to cefuroxime 125 per tablet; historical U.S. RLD currently listed as discontinuedNDA 050605 / Product 001
  • Equivalent to cefuroxime 250 per tablet; historical U.S. RLD currently listed as discontinuedNDA 050605 / Product 002
  • Equivalent to cefuroxime 500 per tablet; historical U.S. RLD currently listed as discontinuedNDA 050605 / Product 003
  • Equivalent to cefuroxime 125 per 5 mL after reconstitution; historical U.S. RLD currently listed as discontinuedNDA 050672 / Product 001
  • Equivalent to cefuroxime 250 per 5 mL after reconstitution; historical U.S. RLD currently listed as discontinuedNDA 050672 / Product 002
  • Equivalent to cefuroxime 125 mg per 5 mL after reconstitution; the public record does not establish an individual's millilitresDIN 02212307

EDITORIAL RECORD

Who prepared and checked this page

Byline
OriginDrug Content Editorial
Review role
Public primary-source verification
Last reviewed
2026-08-29
Source record
4 clickable primary-source entry points are listed with this dossier.

The review role checks source traceability, stated market, document version and product-identity fields. It is not a claim of clinical licensure, prescribing authority or individual pharmacy service. Read the editorial policy.

Search records
Enlarged public-label image